| Name | Title | Contact Details |
|---|
Resolution Health Strategies is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JPS Health Network is a $950 million, tax-supported health care system for Tarrant County in North Texas. Anchored by a 537-bed acute care hospital, the network includes more than 46 community-based clinics, including 20 school-based clinics. John Peter Smith Hospital is home to Tarrant County`s first and only Level 1 Trauma Center, its only psychiatric emergency services site and has the largest family medicine residency program in the nation. Our network employs more than 6,500+ people.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
BGHS is a state-licensed, non-profit behavioral healthcare provider located in Ansonia, CT, serving the citizens of the Lower Naugatuck Valley and surrounding communities. One out of every five Americans suffers from some form of mental illness. Each